You are here

Home

Biblio

Author Title Type [ Year(Desc)]
Filters: Keyword is Genetic Predisposition to Disease  [Clear All Filters]
2020
Pathak GA, Zhou Z, Silzer TK, Barber RC, Phillips NR.  2020.  Two-stage Bayesian GWAS of 9576 individuals identifies SNP regions that are targeted by miRNAs inversely expressed in Alzheimer's and cancer.. Alzheimers Dement. 16(1):162-177.
2021
Horimoto ARVR, Xue D, Thornton TA, Blue EE.  2021.  Admixture mapping reveals the association between Native American ancestry at 3q13.11 and reduced risk of Alzheimer's disease in Caribbean Hispanics.. Alzheimers Res Ther. 13(1):122.
Patel D, Zhang X, Farrell JJ, Chung J, Stein TD, Lunetta KL, Farrer LA.  2021.  Cell-type-specific expression quantitative trait loci associated with Alzheimer disease in blood and brain tissue.. Transl Psychiatry. 11(1):250.
de Rojas I, Moreno-Grau S, Tesi N, Grenier-Boley B, Andrade V, Jansen IE, Pedersen NL, Stringa N, Zettergren A, Hernández I et al..  2021.  Common variants in Alzheimer's disease and risk stratification by polygenic risk scores.. Nat Commun. 12(1):3417.
Chia R, Sabir MS, Bandres-Ciga S, Saez-Atienzar S, Reynolds RH, Gustavsson E, Walton RL, Ahmed S, Viollet C, Ding J et al..  2021.  Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture.. Nat Genet. 53(3):294-303.
Wang H, Bennett DA, De Jager PL, Zhang Q-Y, Zhang H-Y.  2021.  Genome-wide epistasis analysis for Alzheimer's disease and implications for genetic risk prediction.. Alzheimers Res Ther. 13(1):55.
He Z, Liu L, Wang C, Le Guen Y, Lee J, Gogarten S, Lu F, Montgomery S, Tang H, Silverman EK et al..  2021.  Identification of putative causal loci in whole-genome sequencing data via knockoff statistics.. Nat Commun. 12(1):3152.
Baird DA, Liu JZ, Zheng J, Sieberts SK, Perumal T, Elsworth B, Richardson TG, Chen C-Y, Carrasquillo MM, Allen M et al..  2021.  Identifying drug targets for neurological and psychiatric disease via genetics and the brain transcriptome.. PLoS Genet. 17(1):e1009224.
Novikova G, Kapoor M, Tcw J, Abud EM, Efthymiou AG, Chen SX, Cheng H, Fullard JF, Bendl J, Liu Y et al..  2021.  Integration of Alzheimer's disease genetics and myeloid genomics identifies disease risk regulatory elements and genes.. Nat Commun. 12(1):1610.
Kirola L, Budde JP, Wang F, Norton J, Morris JC, Cruchaga C, Fernández MVictoria.  2021.  Lack of evidence supporting a role for DPP6 sequence variants in Alzheimer's disease in the European American population.. Acta Neuropathol. 141(4):623-624.
Kunkle BW, Schmidt M, Klein H-U, Naj AC, Hamilton-Nelson KL, Larson EB, Evans DA, De Jager PL, Crane PK, Buxbaum JD et al..  2021.  Novel Alzheimer Disease Risk Loci and Pathways in African American Individuals Using the African Genome Resources Panel: A Meta-analysis.. JAMA Neurol. 78(1):102-113.
Sariya S, Felsky D, Reyes-Dumeyer D, Lali R, Lantigua RA, Vardarajan B, Jimenez-Velazquez IZ, Haines JL, Shellenberg GD, Pericak-Vance MA et al..  2021.  Polygenic Risk Score for Alzheimer's Disease in Caribbean Hispanics.. Ann Neurol. 90(3):366-376.
Patel D, Zhang X, Farrell JJ, Lunetta KL, Farrer LA.  2021.  Set-Based Rare Variant Expression Quantitative Trait Loci in Blood and Brain from Alzheimer Disease Study Participants.. Genes (Basel). 12(3)
Amlie-Wolf A, Kuksa PP, Lee C-Y, Mlynarski E, Leung YYee, San Wang L-.  2021.  Using INFERNO to Infer the Molecular Mechanisms Underlying Noncoding Genetic Associations.. Methods Mol Biol. 2254:73-91.

Pages

Theme by Danetsoft and Danang Probo Sayekti inspired by Maksimer